Neoplasms, Hematologic Completed Phase 2 Trials for Panobinostat (DB06603)
Also known as: Hematologic Neoplasm / Hematologic Neoplasms
| Indication | Status | Phase |
|---|---|---|
| DBCOND0056760 (Neoplasms, Hematologic) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01802879 | Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator | Treatment |